BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21239774)

  • 1. Prognostic markers and stratification of chronic lymphocytic leukemia.
    Furman RR
    Hematology Am Soc Hematol Educ Program; 2010; 2010():77-81. PubMed ID: 21239774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD49d and CD26 are independent prognostic markers for disease progression in patients with chronic lymphocytic leukemia.
    Ibrahem L; Elderiny WE; Elhelw L; Ismail M
    Blood Cells Mol Dis; 2015 Aug; 55(2):154-60. PubMed ID: 26142332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-based markers as prognostic factors in chronic lymphocytic leukemia.
    Sevov M; Rosenquist R; Mansouri L
    Expert Rev Hematol; 2012 Feb; 5(1):69-79. PubMed ID: 22272707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXP1 and BCL2 show similar immunoenzymatic pattern in bone marrow trephines of chronic lymphocytic leukemia patients.
    Korać P; Vintar MG; Ajduković R; Kardum Paro MM; Jaksić B; Dominis M
    Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):500-4. PubMed ID: 19417623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and risk stratification in chronic lymphocytic leukemia.
    Parikh SA; Shanafelt TD
    Semin Oncol; 2016 Apr; 43(2):233-40. PubMed ID: 27040701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.
    Van Damme M; Crompot E; Meuleman N; Mineur P; Dessars B; El Housni H; Bron D; Lagneaux L; Stamatopoulos B
    Epigenetics; 2014 Oct; 9(10):1374-81. PubMed ID: 25437053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel prognostic gene mutations identified in chronic lymphocytic leukemia and their impact on clinical practice.
    Campregher PV; Hamerschlak N
    Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):271-6. PubMed ID: 24548608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.
    Nabhan C; Raca G; Wang YL
    JAMA Oncol; 2015 Oct; 1(7):965-74. PubMed ID: 26181643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Factors in the Era of Targeted Therapies in CLL.
    Boddu P; Ferrajoli A
    Curr Hematol Malig Rep; 2018 Apr; 13(2):78-90. PubMed ID: 29473123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status.
    Garcia CF; Hunt KE; Kang H; Babb A; Gale JM; Vasef MA; Reichard KK
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):119-27. PubMed ID: 19826250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of chronic lymphocytic leukemia: an update.
    Inamdar KV; Bueso-Ramos CE
    Ann Diagn Pathol; 2007 Oct; 11(5):363-89. PubMed ID: 17870025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere analysis to predict chronic lymphocytic leukemia outcome: a STELA test to change clinical practice?
    Pepper C; Baird D; Fegan C
    Expert Rev Hematol; 2014 Dec; 7(6):701-3. PubMed ID: 25308469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein lipase SNPs rs13702 and rs301 correlate with clinical outcome in chronic lymphocytic leukemia patients.
    Rombout A; Stamatopoulos B; Lagneaux L; Lust S; Offner F; Naessens E; Vanderstraeten H; Verhasselt B; Philippé J
    PLoS One; 2015; 10(3):e0121526. PubMed ID: 25811490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing Molecular Signatures for Chronic Lymphocytic Leukemia.
    Cornet E; Debliquis A; Rimelen V; Civic N; Docquier M; Troussard X; Drénou B; Matthes T
    PLoS One; 2015; 10(6):e0128990. PubMed ID: 26046539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in chronic lymphocytic leukemia-what do we need to know?
    Cramer P; Hallek M
    Nat Rev Clin Oncol; 2011 Jan; 8(1):38-47. PubMed ID: 20956983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
    Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
    Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ZAP-70 in B-cell chronic lymphocytic leukemia: clinical significance and methods of detection].
    Smolej L; Saudková L; Spacek M; Kozák T
    Vnitr Lek; 2006 Dec; 52(12):1194-9. PubMed ID: 17299914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New prognostic markers in CLL.
    Montserrat E
    Hematology Am Soc Hematol Educ Program; 2006; ():279-84. PubMed ID: 17124073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic lymphocytic leukemia.
    Ghia P; Ferreri AM; Caligaris-Cappio F
    Crit Rev Oncol Hematol; 2007 Dec; 64(3):234-46. PubMed ID: 17544290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of diagnostic and prognostic parameters (including flow cytometry) in chronic lymphoproliferative disorders: the Indian perspective.
    Kumar N; Varma N; Varma S; Malhotra P
    Anal Quant Cytol Histol; 2009 Oct; 31(5):296-303. PubMed ID: 20701097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.